Judge approves $7.25bn settlement for Roundup weedkiller cancer claims
A Missouri judge on Friday approved a $7.25bn (£5.5bn) settlement stemming from lawsuits alleging that Bayer’s weedkiller Roundup causes cancer. Judge Timothy Boyer said the settlement was “fair, reasonable, and adequate”. Bayer, the German bio-tech giant, had proposed 0ayi g the $7.25bn to definitively resolve a legal battle in the US. The nationwide settlement will […]
A Missouri judge has approved a $7.25 billion settlement over lawsuits claiming that Bayer's weedkiller Roundup causes cancer. Judge Timothy Boyer deemed the settlement "fair, reasonable, and adequate." Bayer, the German biotech company, had proposed paying $7.25 billion to settle the legal dispute in the United States. The nationwide settlement will benefit those already diagnosed with non-Hodgkin lymphoma and those who develop the disease in the future.
Bayer has already spent approximately $10 billion to resolve related litigation. The compensation amounts to participants range from $10,000 to $165,000 based on usage frequency, diagnosis timing, and disease severity. Bayer will make annual contributions to the fund for up to 21 years, potentially reaching $7.25 billion. Some attorneys argued the settlement funds were insufficient, but the judge opted against delaying payouts to the sick victims.
Bayer maintains its Roundup product does not cause cancer. The settlement follows a June Supreme Court ruling in favor of Bayer, overturning a $1.25 million settlement for a Missouri man alleging Roundup, and its ingredient glyphosate, caused his non-Hodgkin lymphoma.
Rewritten by urgent.news; may contain errors — check the original.
This story
This is one outlet's version. Read the fullest account.